Similar articles

• Intravenous immunoglobulins in the treatment of immune neuropathies.

  Kieseier BC, Meyer Zu Hörste G, Lehmann HC, Gold R, Hartung HP. Kieseier BC, et al. Curr Opin Neurol. 2008 Oct;21(5):555-62. doi: 10.1097/WCO.0b013e32830efc03. Curr Opin Neurol. 2008. PMID: 18769249 Review.
• High-dose intravenous immunoglobulin therapy in dysimmune neuropathies.

  Nobile-Orazio E, Bersano A. Nobile-Orazio E, et al. Neurol Sci. 2002 Apr;23 Suppl 1:S25-32. doi: 10.1007/s100720200012. Neurol Sci. 2002. PMID: 12032584 Review. No abstract available.
• Treatment of immune-mediated, dysimmune neuropathies.

  Finsterer J. Finsterer J. Acta Neurol Scand. 2005 Aug;112(2):115-25. doi: 10.1111/j.1600-0404.2005.00448.x. Acta Neurol Scand. 2005. PMID: 16008538 Review.
• [Treatment of certain immune deficient peripheral neuropathies with intravenous immunoglobulins].

  Pouget J. Pouget J. Rev Prat. 1994 Nov 15;44(18):2404-6. Rev Prat. 1994. PMID: 7855497 French. No abstract available.
• [Treatment of peripheral neuropathies associated with IgM anti-myelin monoclonal gammopathy].

  Mariette X, Oksenhendler E. Mariette X, et al. Rev Neurol (Paris). 1996 May;152(5):413-6. Rev Neurol (Paris). 1996. PMID: 8881442 Review. French.